Recent Press Releases

Amgen Provides Update On Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma

THOUSAND OAKS, Calif., April 4, 2014 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced top-line resul

Janssen Initiates Phase 3 OPTIMIST Trials of Once-Daily Simeprevir in Combination with Once-Daily Sofosbuvir for the Treatment of Genotype 1 Chronic Hepatitis C

Janssen Initiates Phase 3 OPTIMIST Trials of Once-Daily Simeprevir in Combination with Once-Daily Sofosbuvir for the Treatment of Genotype 1 Chronic Hepatitis C OPTIMIST represents the first Phase 3...

Merck Promotes Internal Top Managers to Head Merck Millipore and Consumer Health Divisions

Merck Promotes Internal Top Managers to Head Merck Millipore and Consumer Health Divisions · Consumer Health CEO Udit Batra to lead Merck Millipore division • Allergopharma...

Johnson & Johnson Enters Agreement to be Official Healthcare Partner of the USO

BETHESDA, Md., April 1, 2014 /PRNewswire/ --Johnson & Johnson JNJ +0.24% announced it has entered a multi-year agreement to be the Official Healthcare Partner of the USO. The announcement was...

Par Pharmaceutical Names Terrance J. Coughlin Chief Operating Officer

Par Pharmaceutical Names Terrance J. Coughlin Chief Operating Officer Woodcliff Lake, NJ, April 1, 2014 – Par Pharmaceutical Companies, Inc. today announced that Terrance J. Coughlin has been...

Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel(R) Tdap Vaccine to Include Persons 10 Years of Age

Sanofi Pasteur Announces FDA Has Expanded Age Indication of Adacel(R) Tdap Vaccine to Include Persons 10 Years of Age SWIFTWATER, Pa., April 1, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines...

Medicines Patent Pool, ViiV Healthcare Sign Licence for the Most Recent HIV Medicine to Have Received Regulatory Approval

Medicines Patent Pool, ViiV Healthcare Sign Licence for the Most Recent HIV Medicine to Have Received Regulatory Approval Access to dolutegravir could improve millions of lives in developing...

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool London 1st April 19.30 BST/20.30 EST - Timely collaborations underscore ViiV...

Abbott Hosts Conference Call for First-Quarter Earnings

ABBOTT PARK, Ill., April 1, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2014 financial results on

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

- Timely collaborations underscore ViiV Healthcare's commitment to increase access to life-saving HIV medicines for children and adults in the developing world

Eli Lilly and Company Expands Authorized Generic Agreements with Prasco®

- Prasco to market the Authorized Generic of EVISTA® in the United States

CINCINNATI, April 1, 2014

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool - Timely collaborations underscore ViiV Healthcare's commitment to increase...

Actavis Acquires Silom Medical Company

Actavis Acquires Silom Medical Company - Establishes Leading Position in Fast-Growing Thai Pharmaceutical Market - Immediately Accretive to Non-GAAP Earnings - Enhances Actavis' Growth Platform...

U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022

U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022 INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District...

Results from phase III patient preference study of GSK's Votrient® (pazopanib) vs. Sutent® (sunitinib) in advanced renal cell carcinoma published in Journal of Clinical Oncology

Results from phase III patient preference study of GSK's Votrient® (pazopanib) vs. Sutent® (sunitinib) in advanced renal cell carcinoma published in Journal of Clinical Oncology Data from the...

Johnson & Johnson Announces Acceptance Of Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics

NEW BRUNSWICK, N.J., March 31, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that it

U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022

INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S.

Mylan Comments on U.S. Supreme Court's Consideration of the Standard of Review of Patent Claim Construction

Mylan Comments on U.S. Supreme Court's Consideration of the Standard of Review of Patent Claim Construction PITTSBURGH, March 31, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced that...